BiotechObserver @BiotechObserve

Investing in biotech College Park, MD Joined March 2022

Tweets

19
Followers

123
Following

214
Likes

164

Scott Gottlieb, MD 🇺🇸 @ScottGottliebMD

4 weeks ago

This is a smart policy from FDA and @DrMakaryFDA: Among other things, it would also prioritize generic drug submissions where the generic medicine is slated to be manufactured in the U.S. -- a move that will help address supply chain vulnerabilities. thehill.com/policy/healthc…

0 31 622 190K 10

Scott Gottlieb, MD 🇺🇸 @ScottGottliebMD

4 months ago

My op-ed on the large shift of drug discovery moving to China and policy steps the U.S. can take to keep the innovation economy in America. "Five years ago, U.S. drug makers didn’t license any new drugs from China. By 2024, 1/3 came from Chinese biotech" statnews.com/2025/05/06/how…

3 193 581 541K 110

Marc Andreessen 🇺🇸 @pmarca

3 years ago

This is why I say building new infrastructure is now illegal. It doesn't matter how much money we pour into things like this, they simply will not come to be.

Alec Stapp @AlecStapp

3 years ago

This is why I say building new infrastructure is now illegal. It doesn't matter how much money we pour into things like this, they simply will not come to be.

46 175 2K 826K 81

Download Image

97 220 2K 870K 90

Jason Furman @jasonfurman

3 years ago

You probably want to revise your views on inflation and it’s overall dynamic more based on today’s jobs report than any other data report this entire year. And not in a favorable direction.

82 119 808 0 44

Jeffrey Gundlach @TruthGundlach

3 years ago

The 10 year UST yield is falling as the Fed speaks of rate hikes.

70 74 742 0 16

Paras Sharma @paras_biotech

3 years ago

Exciting step towards getting proof-of-biology in Ph2 study for first-in-class, peripherally-acting, CB1 inverse agonists - from our portfolio company Inversago Pharma inversago.com/en/ *emerging obesity treatment ecosystem 👇

Genesys Capital @GenesysCapital

3 years ago

0 0 4 0 0

0 4 20 0 3

Download Image

Matthew Herper @matthewherper

3 years ago

For Eisai, success against Alzheimer's has been long time coming. Great read from ⁦@adamfeuerstein⁩, ⁦@damiangarde⁩, and ⁦@Jasonmmast⁩. statnews.com/2022/11/17/we-…

2 6 13 0 2

Paras Sharma @paras_biotech

3 years ago

Most competitive gene-therapy indications **mapped out from ~800 disclosed programs, including ~200 clinical stage, from over 170 companies From Evercore

11 43 241 0 75

Download Image

Scott Wapner @ScottWapnerCNBC

3 years ago

Fortune favors the _______

438 15 174 0 1

Jacob Plieth @JacobPlieth

3 years ago

Stifel: We're not exactly sure what to make of the $BIIB hire, though it’s a little surprising - on the one hand he has extensive industry experience, while on the other he has spent the better part of the last decade as an investor.

0 1 1 0 0

Zach Brennan @ZacharyBrennan

3 years ago

Starting with ADC, FDA calls for fully enrolled confirmatory trial prior to accelerated approval submission - endpts.com/starting-with-…

2 10 23 0 4

Matthew Herper @matthewherper

3 years ago

FDA places clinical hold on Verve gene-editing treatment, by ⁦@adamfeuerstein⁩. statnews.com/2022/11/07/fda…

0 1 2 0 1

BiotechObserver @BiotechObserve

3 years ago

Friend in Nevada said same thing happening there. Rumor is lower than predicted turnout for Ds.

Dave Wasserman @Redistrict

3 years ago

Friend in Nevada said same thing happening there. Rumor is lower than predicted turnout for Ds.

1K 2K 17K 0 202

1 0 2 0 0

Ehsan Masood @EhsanMasood

3 years ago

And finally, here's our story in this week's @Nature nature.com/articles/d4158…. Huge thanks to the awesome @RichMonastersky my colleague and commissioning editor.

0 6 15 0 4

Liz Thomas @LizThomasStrat

3 years ago

Bank of England sees inflation peaking at 11% in Q4. Woof.

30 25 194 0 0

Lenore Skenazy @FreeRangeKids

3 years ago

Nature Mag: "Adolescence is a time of opportunity, as well as a time of risk-taking." When we don't let young people spread their wings because WE'RE scared, they miss out on crucial growth time of curiosity, competence, comfort in the world. #LetGrow nature.com/articles/d4158…

0 16 62 0 4

Viraj Patel @VPatelFX

3 years ago

⚠️ The one chart that shows the BoE & Chancellor still have their work cut out. Bid-ask spreads for longer-dated gilts increased sharply after Truss' speech on Fri. Sign of liquidation by pension funds/real money investors. BoE will have to step in if this continues on Mon $GBP